National Engineering Research Center of Immunological Products
Si-Jia Sun is currently a PhD student in the Division of Cardiology, Department of Medicine, the University of Hong Kong in Hong Kong, China. He received his undergraduate degree from Soochow University, Suzhou, Jiangsu, China.
During PhD career, his research focuses on pluripotent stem cell for treatment of cardiovascular disease and small and large animal models for studying the mechanism and treatment of post-myocardial infarction heart failure. Moreover, he also takes part in prof. Song-Yan Liao's and prof. Hung-Fat Tse's research projects and is responsible for animal model establishment including porcine hypertension model, acute and chronic porcine or murine post-myocardial infarction models and murine hindlimb ischemia model.
Currently, his research is sought to determine whether pre-transplantation systemic intravenous administration of human induced pluripotent stem cell (hiPSC)-derived mesenchymal stromal cells (hiPSC-MSCs) could improve the survival and therapeutic efficacy of locally transplanted cells in a mouse model of myocardial infarction (MI) or hindlimb ischemia.
Construction of Benzene Rings by Copper-Catalyzed Cycloaddition Reactions of Oximes and Maleimides: An Access to Fused Phthalimides.
Organic letters Feb, 2018 | Pubmed ID: 29411987
Synthetic Lipopeptide Enhances Protective Immunity Against Infection.
Frontiers in immunology , 2019 | Pubmed ID: 31258538
Grincamycin B Functions as a Potent Inhibitor for Glioblastoma Stem Cell via Targeting RHOA and PI3K/AKT.
ACS chemical neuroscience Aug, 2020 | Pubmed ID: 32584547
Development of Different Methods for Preparing Outer Membrane Vesicles Vaccine: Impact of Preparation Method on Protective Efficacy.
Frontiers in immunology , 2020 | Pubmed ID: 32655550
HtrA family proteases of bacterial pathogens: pros and cons for their therapeutic use.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases Apr, 2021 | Pubmed ID: 33359376
Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa.
Nanomaterials (Basel, Switzerland) Jan, 2022 | Pubmed ID: 35055244
Light-Triggered Self-Assembly of Peptide Nanoparticles into Nanofibers in Living Cells through Molecular Conformation Changes and H-Bond Interactions.
ACS nano Nov, 2022 | Pubmed ID: 36354757
Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge.
Biomaterials Nov, 2022 | Pubmed ID: 36436305
mRNA-based platform for preventing and treating by targeted staphylococcal enterotoxin B.
Frontiers in immunology , 2024 | Pubmed ID: 39640268
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved